Back
iShares Paris-Aligned Clmt MSCI USA ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
79
PABU
iShares Paris-Aligned Clmt MSCI USA ETF
Last Price:
65.71
Seasonality Move:
13.32%
Buy
71
LBPH
Longboard Pharmaceuticals
Last Price:
59.81
Seasonality Move:
76.52%
Buy
79
iShares Paris-Aligned Clmt MSCI USA ETF (PABU)
is a Buy
Is iShares Paris-Aligned Clmt MSCI USA ETF a Buy, Sell or Hold?
- The current iShares Paris-Aligned Clmt MSCI USA ETF [PABU] share price is $65.81. The Score for PABU is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PABU is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $59.81. The Score for LBPH is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PABU Stock Price Chart
What is iShares Paris-Aligned Clmt MSCI USA ETF's stock price today?
-
The iShares Paris-Aligned Clmt MSCI USA ETF share price today is $65.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PABU is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $59.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight buying pressure.
PABU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 67.82 | Buy |
| Chaikin Money Flow: | 9891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.98 - 64.56) | Buy |
| Bollinger Bands (100): | (59.74 - 63.48) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.9 | Buy |
| Relative Strength Index (14 RSI): | 80.76 | Buy |
| Chaikin Money Flow: | 220026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.09 - 64.17) | Buy |
| Bollinger Bands (100): | (27.18 - 49.32) | Buy |
PABU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.88 | Buy |
| 20-day SMA: | 63.91 | Buy |
| 50-day SMA: | 62.99 | Buy |
| 200-day SMA: | 58.85 | Buy |
| 8-day EMA: | 64.39 | Buy |
| 20-day EMA: | 63.87 | Buy |
| 50-day EMA: | 63 | Buy |
| 200-day EMA: | 58.92 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.71 | Buy |
| 20-day SMA: | 58.5 | Buy |
| 50-day SMA: | 43.59 | Buy |
| 200-day SMA: | 29.2 | Buy |
| 8-day EMA: | 59.5 | Buy |
| 20-day EMA: | 55.86 | Buy |
| 50-day EMA: | 47.38 | Buy |
| 200-day EMA: | 31.5 | Buy |
iShares Paris-Aligned Clmt MSCI USA ETF Earnings Growth & PABU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.44 per share.
iShares Paris-Aligned Clmt MSCI USA ETF Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||